Actylis Acquires Pharm-Rx
October 7, 2024
Actylis has acquired Pharm-Rx, a Saddle Brook, New Jersey-based supplier of specialty ingredients for the vitamin, mineral and supplement (VMS), OTC and pharmaceutical markets. The deal expands Actylis' nutrition and OTC capabilities and supplier partnerships; Pharm-Rx will continue to operate under its brand and Mark Bostel will become President, Global Nutrition and OTC for Actylis. Financial terms were not disclosed.
- Buyers
- Actylis
- Targets
- Pharm-Rx
- Industry
- Pharmaceuticals
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
VitaWorks Acquires Phlex Nutritional Manufacturing to Expand U.S. Production and Innovation Capabilities
April 22, 2026
Healthcare Services
VitaWorks acquired Phlex Nutritional Manufacturing, a 70,000-square-foot facility in Phoenix, Arizona, to expand its production capacity and technical capabilities for health and wellness products. The purchase adds advanced high-speed powder filling, pouching, stick pack production, packet manufacturing, and specialized probiotic and effervescent production capabilities, alongside a new Döhler Flavor Lab partnership within the facility.
-
Agno Pharma Acquires Actylis Eugene (Legacy Cascade Chemistry) in Eugene, Oregon
January 15, 2026
Pharmaceuticals
Agno Pharma has acquired Actylis Eugene, the legacy Cascade Chemistry manufacturing asset in Eugene, Oregon, expanding Agno's U.S. cGMP API development and manufacturing footprint. The site includes a 16,000 sq. ft. R&D lab and a newly constructed 30,000 sq. ft. GMP manufacturing facility, enhancing Agno's capabilities to support biotech and pharmaceutical clients from early-phase through commercial API production.
-
Medvantx Acquires RxS
July 8, 2025
Healthcare Services
Medvantx, a San Diego-based pharmacy services provider, has acquired RxS, a multichannel sample management and accountability solutions company headquartered in Manalapan, New Jersey. The acquisition integrates RxS’s sampling and engagement technology with Medvantx’s patient access, PAP fulfillment, telehealth and distribution services to broaden capability and accelerate access for pharmaceutical and device manufacturers.
-
22nd Century Group Acquires RX Pharmatech Ltd
January 24, 2023
Food & Beverage
22nd Century Group, through its GVB Biopharma business, acquired UK-based RX Pharmatech Ltd, a distributor of cannabinoid/CBD products and holder of numerous U.K. novel food applications. The deal includes $650,000 up-front in cash and stock plus a three-year equity earn-out tied to revenue milestones and aims to strengthen 22nd Century's access and distribution in the U.K. and EU consumer CBD market.
-
AmerisourceBergen Acquires PharmaLex for €1.28 Billion
December 31, 2022
Healthcare Services
AmerisourceBergen Corporation signed a definitive agreement to acquire PharmaLex Holding GmbH for €1.28 billion in cash. The deal is intended to expand AmerisourceBergen’s global biopharma services platform by adding PharmaLex’s tech-enabled, regulatory-focused life sciences expertise.
-
New Mountain-backed Actylis Integrates Aceto and 10 Specialty Ingredients Businesses
September 26, 2022
Manufacturing
New Mountain Capital’s new platform Actylis launched by combining Aceto and ten acquired specialty ingredient manufacturers and sourcing firms into a single global company. The combined business unites GMP and non‑GMP manufacturing, R&D, quality and sourcing capabilities across multiple countries to supply critical raw materials for pharmaceuticals, nutrition, cosmetics, agriculture and specialty chemicals.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.